Vraylar, illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Vraylar

Cariprazine

Prescription required

$591.00

1.5mg · 3 × 30 tablets · 3 months supply

BrandBranded medicine· By Allergan

$197.00 per month

Strength

How long a supply?

1 month$197.00 a month
3 months$197.00 a month
6 months$197.00 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$2364a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

1.5mg

3mg

4.5mg

6mg

FDA boxed warningIncreased mortality in elderly patients with dementia-related psychosis

and SUICIDAL THOUGHTS AND BEHAVIORS

Increased Mortality in Elderly Patients with Dementia-Related Psychosis

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for the treatment of patients with dementia-related psychosis

Suicidal Thoughts and Behaviors

WARNING

Read this with the rest of the clinical information

About Vraylar

Overview

Vraylar contains cariprazine, an atypical antipsychotic. It treats schizophrenia in adults and children aged 13 and older, and acute manic or mixed episodes of bipolar I disorder in adults and children aged 10 and older. In adults, it also treats bipolar I depression and is used alongside antidepressants to treat major depressive disorder. Exactly how it works is unknown, but its effects may involve acting on receptors for dopamine and serotonin in the brain.

What it treats

- Schizophrenia in adults and children aged 13 years and older. - Acute manic or mixed episodes associated with bipolar I disorder in adults and children aged 10 years and older. - Depressive episodes associated with bipolar I disorder (bipolar depression) in adults. - Major depressive disorder in adults, as an add-on to antidepressant treatment.

Safety information

Side effects

Common side effects of Vraylar include restlessness or feeling unable to sit still, movement problems such as tremor or stiffness, nausea, vomiting, indigestion, sleepiness, tiredness, constipation, trouble sleeping, increased appetite and dizziness. Which side effects are most common varies with the condition being treated. Serious risks include suicidal thoughts or behaviours; neuroleptic malignant syndrome; tardive dyskinesia (involuntary movements); high blood sugar or diabetes; changes in blood fats and weight gain; low white blood cell counts; a drop in blood pressure when standing, fainting and falls; seizures; difficulty swallowing; and problems regulating body temperature. Contact a doctor promptly if you develop concerning side effects. Seek immediate medical help for suicidal thoughts or behaviours, a seizure or a suspected stroke. Older adults with dementia-related psychosis have an increased risk of stroke and death. Vraylar can affect thinking and movement, so use caution when operating machinery. Side effects may appear late because the medicine remains in the body for a long time. Monitoring is needed for several weeks after starting treatment and after each dose change. Your doctor should monitor blood sugar, blood fats and weight, and may need to check blood pressure, heart rate and white blood cell counts.

FDA boxed warning

Increased mortality in elderly patients with dementia-related psychosis

and SUICIDAL THOUGHTS AND BEHAVIORS

Increased Mortality in Elderly Patients with Dementia-Related Psychosis

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for the treatment of patients with dementia-related psychosis

Suicidal Thoughts and Behaviors

WARNING

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

When to call your doctor

• Seek medical attention immediately for thoughts of suicide or suicidal behavior. • Get urgent medical help if you have a seizure. • Seek immediate medical attention if you faint. • Get urgent medical help if you have difficulty swallowing.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

Do not take Vraylar if you have had an allergic reaction to cariprazine. Reported reactions include rash, itching, hives, and swelling of the tongue, lips, face or throat. Conditions requiring caution or monitoring include: • Dementia-related psychosis in older adults, because of an increased risk of stroke or transient ischemic attack. • Diabetes or high blood sugar, abnormal blood fats, or weight gain. • Low white blood cell counts or a history of low white blood cells; blood counts should be monitored. • Heart or blood vessel disease, a history of stroke, dehydration, or a risk of fainting; heart rate and blood pressure should be monitored. • A history of seizures or conditions that increase seizure risk. • Pregnancy, because animal studies suggest a risk of harm to the unborn baby. Vraylar can cause neuroleptic malignant syndrome, which requires immediate discontinuation and close monitoring, and tardive dyskinesia, which may require discontinuation. Side effects may appear late, so monitoring is needed for several weeks after starting treatment and after each dose change. Use caution when operating machinery because Vraylar may impair thinking and movement.

Interactions

Medicines that strongly or moderately block the enzyme CYP3A4 can increase levels of cariprazine and its major active breakdown product in the body. If taken together, your prescriber will need to reduce your Vraylar dose. Taking Vraylar with medicines that increase CYP3A4 activity, called CYP3A4 inducers, is not recommended. Their effect on Vraylar levels has not been studied and is unclear. Discuss any medicines you take with your doctor to check for these interactions.

Using Vraylar

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label VRAYLAR (CARIPRAZINE) CAPSULE, GELATIN COATED VRAYLAR (CARIPRAZINE) KIT [ALLERGAN, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines